Skip to content
phase 1Immune & Inflammation

Thymulin

Also known as: Facteur Thymique Sérique, FTS, Serum Thymic Factor, FTS-Zn, Thymulin-Zinc Complex

Thymulin is a zinc-dependent nonapeptide (9 amino acids) produced exclusively by thymic epithelial cells. It is the only thymic hormone that requires zinc binding for biological activity, forming the FTS-Zn complex that drives T-cell differentiation and maturation. Thymulin levels decline sharply with age and thymic involution, and research has explored its potential in restoring immune function, modulating inflammation, and treating zinc-deficiency-related immune dysfunction.

3 cited references·5 researched benefits

Quick Answer

Thymulin is a nine-amino-acid peptide produced by thymic epithelial cells that requires zinc binding for biological activity. It promotes T-cell differentiation, modulates cytokine production, and plays a key role in immune system maturation. Thymulin levels decline significantly with age as the thymus involutes, contributing to age-related immune decline. Phase 1 research has explored its potential for restoring immune function in elderly and immunocompromised populations.

Key Facts

Mechanism
Thymulin binds zinc in a 1:1 stoichiometric ratio to form the biologically active FTS-Zn complex. This complex binds to high-affinity receptors on T-cell progenitors, promoting differentiation of CD4+ and CD8+ T-cells, enhancing T-cell cytotoxicity, and modulating the CD4/CD8 ratio. It stimulates IL-2 production and IL-2 receptor expression on T-cells, suppresses excessive pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), and influences the hypothalamic-pituitary-adrenal axis. Thymulin also enhances NK cell activity and modulates pain perception through endorphin-related pathways.
Research Status
phase 1
Half-Life
~minutes (rapid degradation in serum)
Molecular Formula
C₃₃H₅₄N₁₂O₁₅Zn
Primary Use
Immune & Inflammation
Table of Contents

Benefits

  • Restores T-cell differentiation and maturation in age-related thymic involutionmoderate
  • Modulates inflammatory cytokines — reduces TNF-α, IL-1β, and IL-6 in experimental modelsmoderate
  • Analgesic properties — inhibits hyperalgesia through peripheral and central endorphin-dependent mechanismspreliminary
  • May reverse immune dysfunction associated with zinc deficiency, particularly in elderly populationsmoderate
  • Neuroprotective potential — reduces demyelination and neuroinflammation in experimental autoimmune encephalomyelitis modelspreliminary

Dosage Protocols

RouteDosage RangeFrequencyNotes
Subcutaneous injection1–5 mcg/kgDaily or 3× weeklyExperimental dosing from animal and early human studies. Must be co-administered with adequate zinc to maintain biological activity.
Intranasal10–50 mcgDailyInvestigated for neuroprotective applications; intranasal route avoids rapid serum degradation and enables CNS access.

Medical disclaimer

Dosage information is provided for educational reference only. Always follow your prescriber's instructions and consult a qualified healthcare provider before starting any peptide protocol.

Side Effects

  • Injection site irritation or mild rednesscommon
  • Transient low-grade fever due to immune activationrare
  • Zinc-related metallic taste if co-administered with zinc supplementationcommon
  • Theoretical risk of autoimmune exacerbation due to immune stimulation in predisposed individualsserious

Frequently Asked Questions

What is the relationship between thymulin and zinc?
Thymulin is unique among thymic hormones in that it is biologically inactive without zinc. The nonapeptide must bind one zinc ion to form the FTS-Zn complex before it can interact with T-cell receptors. This zinc dependency means that zinc-deficient individuals have reduced functional thymulin levels even if the peptide is produced normally by the thymus. Zinc supplementation in deficient elderly adults has been shown to restore circulating active thymulin levels.
Why do thymulin levels decline with age?
Thymulin is produced exclusively by thymic epithelial cells, and the thymus begins involuting (shrinking and being replaced by fat tissue) after puberty. By age 60, thymic tissue output is reduced by approximately 95%, leading to a dramatic decline in thymulin secretion. This contributes to age-related immune dysfunction (immunosenescence), including reduced T-cell diversity and impaired immune surveillance. Thymulin replacement is one proposed strategy to partially reverse these changes.
How does thymulin differ from Thymosin Alpha-1?
Both are thymic peptides that modulate immunity, but they differ structurally and mechanistically. Thymulin is a 9-amino-acid zinc-dependent peptide produced by thymic epithelial cells that directly drives T-cell differentiation. Thymosin Alpha-1 is a 28-amino-acid peptide that activates toll-like receptors on dendritic cells and enhances overall adaptive immunity. Thymosin Alpha-1 is far more clinically advanced, with approval in over 35 countries, while thymulin remains in early-phase research.
Can thymulin help with pain management?
Animal studies have demonstrated that thymulin has analgesic properties, reducing hyperalgesia through mechanisms involving endogenous opioid pathways. It appears to modulate pain perception at both peripheral and central levels. However, its extremely short half-life (minutes) and the early stage of this research limit practical therapeutic application. Stabilized analogs or alternative delivery methods (such as intranasal administration) are being explored to overcome these limitations.

References

  1. 1
    Thymulin (facteur thymique sérique) and zinc contents of the human thymus(1983)PubMed ↗
  2. 2
    Restoration of impaired T-cell functions in aging by thymulin and zinc supplementation(1988)PubMed ↗
  3. 3
    Anti-inflammatory and analgesic properties of thymulin: modulation by zinc and endorphins(2007)PubMed ↗

Latest Research

Last updated: 2026-02-19